Vernakalant (RSD-1235, MK-6621) is a novel, frequency-dependent Na+ channel and early activating K+ channel blocker that selectively prolongs the atrial refractory period.
[1] I. Stiell, et al. EDWARD A. PANACEK, MD, MPH| VOLUME 48, ISSUE 4, SUPPLEMENT , 46-47,
















